Clinical Trial Update: Evaluate the Efficacy and Safety of TG-2349 in Subjects With Hepatitis C Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of TG-2349 in adults with chronic hepatitis C has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• TG-2349

Snippet

Sponsor: TaiGen Biotechnology Co., Ltd. | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2018-10-12